Mannkind Return on Equity

Mannkind (MNKD) currently reports a ROE of 200.78%. That is above the Healthcare sector average of 13.26%. Use the charts on this page to explore Mannkind's ROE history and peer comparisons.

Mannkind's ROE of 200.78% is higher than the Healthcare sector average of 13.26%. That is roughly 1413.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Mannkind's current 200.78% should be judged against Healthcare norms (sector average: 13.26%) and against MNKD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 200.78%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.26%. From there, open related valuation or income-statement pages for Mannkind, and consider following MNKD for alerts when major investors trade the stock.

Mannkind is classified in the Healthcare sector. On ROE, it currently shows 200.78% versus a sector average near 13.26%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MNKD with unrelated industries.